Evidence map›Paper›PMID 38019424›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2024

Purification of Phytaspases Using a Biotinylated Peptide Inhibitor.

Raisa A Galiullina, Ilya A Dyugay, Andrey B Vartapetian, Nina V Chichkova

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.8field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Raisa A GaliullinaBelozersky Institute of Physico-Chemical Biology, Moscow State University, Moscow, Russia.
Ilya A DyugayFaculty of Bioengineering and Bioinformatics, Moscow State University, Moscow, Russia.
Andrey B VartapetianBelozersky Institute of Physico-Chemical Biology, Moscow State University, Moscow, Russia. varta@belozersky.msu.ru.
Nina V ChichkovaBelozersky Institute of Physico-Chemical Biology, Moscow State University, Moscow, Russia.
Lomonosov Moscow State University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phytaspases are plant subtilisin-like proteases (subtilases) that possess a rarely occurring substrate cleavage specificity. These proteolytic enzymes hydrolyze their substrates strictly after an aspartate residue preceded by a characteristic, though degenerate, tripeptide amino acid motif. Having been initially discovered as proteases involved in the accomplishment of programmed cell death in plants, phytaspases were also demonstrated to be instrumental in specific processing of precursor proteins of several plant peptide hormones, thus generating biologically active peptides. Here we provide a protocol for isolation of active phytaspases from leaves, which was shown to be efficient for a wide range of plant species. The key element of the proposed scheme is the use of a specific and reversible biotinylated peptide aldehyde inhibitor of phytaspases for purification of the enzymes by means of affinity chromatography. We also discuss nuances, pitfalls, and possible alternatives for successful isolation of proteolytically active phytaspases.

Indexed as

Peptide HormonesPeptide HydrolasesAldehydesEndopeptidasesPlant Growth RegulatorsSubtilisinsAldehydesEndopeptidasesPeptide HormonesPeptide HydrolasesPlant Growth Regulatorssubtilase, plantSubtilisinsAffinity purificationAspartate cleavage specificityBiotinylated peptide inhibitorPhytaspasePlant subtilisin-like proteasePrecursor processingProteolytic activity

Identifiers

PMID38019424
OpenAlexW4389147525

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.